Elizabeth B. Carder-Thompson, all library items
Back To Elizabeth B. Carder-Thompson
-
Reed Smith Health Care Reform Review: The Affordable Care Act - Analysis and Implications for DMEPOS Suppliers
July 07, 2010
Suppliers and manufacturers of durable medical equipment (DME), prosthetics, orthotics, and supplies (DMEPOS) will be impacted, directly and indirectly, by numerous provisions of the recently-enacted health reform legislation, H.R. 3590, the Patient Protection and Affordable Care Act (PPACA), as amended by H.R. 4872, the Health Care and Education Reconciliation Act of 2010 (Reconciliation Act), collectively known as the “Affordable Care Act” or ACA.
-
Reed Smith Health Care Reform Review: The Affordable Care Act - Analysis and Implications for Drug, Device and Biotech Manufacturers
June 24, 2010
In April 2010, Reed Smith provided an extensive analysis of the recently-enacted health reform legislation, H.R. 3590, the Patient Protection and Affordable Care Act (PPACA), as amended by H.R. 4872, the Health Care and Education Reconciliation Act of 2010 (Reconciliation Act). Together, these sweeping measures expand access to health insurance (including subsidies, mandates, and market reforms); reduce health care spending (particularly in the Medicare program); expand federal fraud and abuse authorities and transparency requirements; impose new taxes and fees on health industry sectors; and institute a variety of other health policy reforms.In this analysis, we concentrate on those provisions in the new law that will affect life sciences entities: pharmaceutical, device, and biologics manufacturers.
-
Reed Smith Health Care Reform Review: Analysis and Implications of Fraud Abuse and Program Integrity Provisions of the Affordable Care Act
June 03, 2010
In April 2010, Reed Smith provided an extensive analysis of the recently-enacted health reform legislation, H.R. 3590, the Patient Protection and Affordable Care Act (PPACA), as amended by H.R. 4872, the Health Care and Education Reconciliation Act of 2010 (Reconciliation Act). Together, these sweeping measures expand access to health insurance (including subsidies, mandates, and market reforms); reduce health care spending (particularly in the Medicare program); expand federal fraud and abuse authorities and transparency requirements; impose new taxes and fees on health industry sectors; and institute a variety of other health policy reforms. In this analysis, we concentrate on those provisions in the new law that will affect Fraud Abuse and Program Integrity Provisions.
-
Reed Smith Health Care Reform Review - The Patient Protection and Affordable Care Act as amended by the Reconciliation Act
April 09, 2010
On March 23, 2010, President Obama signed into law the Patient Protection and Affordable Care Act (PPACA), a sweeping measure designed to expand access to health insurance, reduce health care spending (particularly in the Medicare program); expand federal fraud and abuse authorities and transparency requirements; impose new taxes and fees on health industry sectors; and institute a variety of other health policy reforms. The President also signed a second bill into law on March 30, 2010, the Health Care and Education Reconciliation Act of 2010 (Reconciliation Act), which includes a series of “fixes” to the PPACA, including substantive changes to the PPACA’s provisions regarding Medicare prescription drug coverage, Medicare Advantage and fee-for-service payments, Stark law self-referral policy, and Medicaid matching payments, among many others. Within the thousands of pages of the new laws are numerous provisions that will have a direct and material impact on nearly every component of the health care delivery and financing systems in the United States, including health insurers, health care providers, and manufacturers of pharmaceuticals and medical devices, as well as employers, taxpayers, and patients. Moreover, the impact of some of these provisions will be felt immediately, as certain provisions are effective upon enactment, and some have January 1, 2010 effective dates. Reed Smith has prepared a major Alert concentrating on those PPACA provisions we believe are of most interest to health care providers and medical device and pharmaceutical manufacturers.
-
CMS Prepares to Re-Launch Medicare DMEPOS Competitive Bidding—Tips for Potential Bidders
May 14, 2009
Client Alert 2009-166
-
AdvaMed Issues Revised Code of Ethics on Interactions with Health Care Professionals
December 19, 2008
Client Alert 2008-225
-
The Medicare Improvements for Patients and Providers Act of 2008: Delay and Reform of the Medicare DMEPOS Competitive Bidding Program
July 28, 2008
Health Care Alert 2008-04
-
Expansion of Medicare DMEPOS Competitive Bidding Announced
January 10, 2008
Health Care Bulletin HC08-01
-
Medicare Clinical Trial Policy: CMS Rejects Major Proposed Revisions
October 26, 2007
In the face of both substantive and procedural concerns, the Centers for Medicare & Medicaid Services (“CMS”) has decided not to adopt significant changes to the Medicare clinical trial national coverage policy that it had proposed on July 19, 2007. Instead, CMS’s July 9, 2007 final clinical trial coverage policy stands.
-
Medicare Competitive Bidding Program for Durable Medical Equipment, Prosthetics, Orthotics and Supplies
May 18, 2007
Health Care Bulletin HC2007-04
-
CMS Issues Proposed Rule to Implement Medicare Competitive Bidding Program & Other Payment Reforms for Durable Medical Equipment, Prosthetics, Orthotics, & Supplies
May 22, 2006
Health Care Bulletin HC2006-05
-
OIG Advisory Opinion 06-02: Management Services Arrangements Between DME Suppliers and Physicians
April 04, 2006
Health Care Bulletin HC2006-02
-
Research Misconduct: New Enforcement Actions and Developments
August 31, 2005
Health Care Bulletin HC2005-08
-
California Update: Law on Compliance Programs for Drug and Device Manufacturers Effective July 1, 2005
May 27, 2005
Health Care Bulletin HC2005-05
-
Research Misconduct: A New Area of Focus for Government Enforcement
May 27, 2005
Health Care Bulletin HC2005-06
-
CMS Issues Final Rule to Implement the New Medicare Part D Outpatient Prescription Drug Program
February 28, 2005
Health Care Bulletin HC2005-02
-
New State Laws on Reporting Marketing Expenses of Drug/Device Manufacturers: California and the District of Columbia
November 29, 2004
Health Care Bulletin HC2004-20
-
Office of Inspector General Supplemental Compliance Program Guidance for Hospitals
July 16, 2004
Health Care Bulletin HC2004-14
-
Medco Settlements
May 13, 2004
Health Care Bulletin HC2004-09
-
The Medicare Prescription Drug, Improvement, and Modernization Act of 2003
December 11, 2003
Health Care Bulletin HC2003-21
-
Vol. VIII, No. 2 (Fall 2003)
November 24, 2003
Health Law Monitor
-
OIG Proposes Clarifications to Exclusionary Rule Prohibiting Excessive Charges
October 01, 2003
Health Care Bulletin HC2003-17
-
House and Senate Pass Separate Versions of Legislation Reforming Medicare and Expanding Medicare Prescription Drug Coverage
July 18, 2003
Health Care Bulletin HC2003-16
-
Office of Inspector General Compliance Program Guidance for Pharmaceutical Manufacturers
May 15, 2003
Health Care Bulletin H2003-12
-
OIG Issues Special Advisory Bulletin on Contractual Joint Ventures
May 05, 2003
Health Care Bulletin HC2003-11
-
CMS Issues Medicare “Inherent Reasonableness” Rule
December 20, 2002
Health Care Bulletin HC2002-24
-
Draft OIG Compliance Program Guidance for Pharmaceutical Manufacturers
November 28, 2002
Health Care Bulletin HC02-20
-
HHS Issues HIPAA Privacy Rule Modifications
August 15, 2002
Health Care Bulletin HC02-16
-
New Rule Proposed to Modify the HIPAA Privacy Regulations
March 26, 2002
Health Care Bulletin HC02-06
-
Proposed Rule for “Medicare-Endorsed Prescription Drug Card Assistance Initiative”
March 14, 2002
Health Care Bulletin HC02-05
-
CMS Issues New Policy Allowing Faxed/Electronic CMNs and Orders
September 24, 2001
Health Care Bulletin HC 01-12
-
HCFA “Educational Symposium” on the Use of Evidence-Based Medicine in the Medicare Coverage Decision Process
May 09, 2001
Health Care Bulletin HC01-08
-
Top Ten Legal Issues Looming for HME Suppliers in 2001
March 01, 2001
-
HCFA’s Final Stark II Regulations With Comment Period (Phase I)
February 28, 2001
Health Care Bulletin HC01-05
-
Final HIPAA Rule Issued on Privacy Standards for Individually Identifiable Health Information
January 04, 2001
Health Care Bulletin HC01-01
-
Final Rule Establishing DMEPOS Supplier Standards
November 01, 2000
Health Care Bulletin HC00-16
-
HCFA Notice On Medicare Coverage Decision Criteria
June 05, 2000
Health Care Bulletin 00-07
-
OIG Special Fraud Alert: Rental Of Space In Physician Offices By Persons Or Entities To Which The Physician Refers
March 03, 2000
Health Care Bulletin 00-02
-
OIG Compliance Program Guidance For The Durable Medical Equipment, Prosthetics, Orthotics And Supply Industry
July 07, 1999
Health Care 99-08
-
OIG Draft Compliance Guidance For The Durable Medical Equipment, Prosthetics, Orthotics And Supply Industry
February 19, 1999
Health Care 99-03
-
OIG Final Rule On Exclusion Authorities
September 23, 1998
Health Care 98-
-
Office of Inspector General’s Compliance Program Guidance For Home Health Agencies
August 28, 1998
Health Care 98-10
-
OIG Advisory Opinion 98-8: DME Charges “Substantially in Excess”
July 07, 1998
Health Care 98-09
-
HCFA Home Health Agency Surety Bond Final Rule And Medicare “Incentive Program” Final Rule With Comment Period
June 12, 1998
Health Care 98-07